
Cardiologist @Yale | Fellowship @BIDMC | Former Chief Resident @YaleIM_Chiefs
Joined March 2022
- Tweets36
- Following216
- Followers176
- Likes55
Merilyn Varghese, MD MSc retweeted
CR participation among US Veterans remains low vs Medicare (10.4% vs 28%), with no sig differences in initiation by sex. Lower socioeconomic status is linked to reduced uptake. More research needed. jacc.org/doi/10.1016/j.jacad…
#JACCAdvances #cvRehab @MerilynVarghese
Merilyn Varghese, MD MSc retweeted
Now in press in @MyJSCAI, our comprehensive review "Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)"
jscai.org/article/S2772-9303…
How should we evaluate women with ischemic heart disease? This our approach
@CesiaGallegos @SpatzErica @CigarroaNatasha @edwardmillermd @WHRYale @YaleCardiology @YaleIMed @InocaInternati1 @heart_spasms
Merilyn Varghese, MD MSc retweeted
Replying to @JAMACardio
@JAMACardio We profiled exercise BP using plasma proteomics in search of new HTN/CVD biomarkers.
TGFBR3 emerged as a novel marker of exercise SBP & incident HTN across multiple cohorts & platforms, supported by genetic/MR experiments
Huge team effort 🙏
bit.ly/4cg5krF
Merilyn Varghese, MD MSc retweeted
Thank you @YaleCancer -> our trainees = why we do this: 4 most recent (May & June 2024) first-author trainee 🌟s @YaleMed @YaleIMed @HopkinsHeme & @NIHCritCare @WaldronCJ @SatokoItoMDPhD #cecilyallen #danielwang @AyeshaButtMD @RhysRichmond
@hmkyale @HannyAlSamkari @CukerMd @cececalhounMD @PishkoMD @redcell_doc @LFiellin @DrNunezSmith @LisaSandersmd @YaleHematology @YaleHemOnc @LaurenMerzMD @justine_ryu @rushadpatell @DawwasGhadeer @MerilynVarghese @HTRSFellows
.@GeorgeGoshuaMD accepts the prestigious NOMIS and @ScienceMagazine Young Explorer Award in Zurich, Switzerland. Read more about Dr. Goshua and his winning essay "Napkin math can change the world."
yalecancercenter.org/news-ar…
@SmilowCancer @YaleMed @YNHH @YaleHematology
Merilyn Varghese, MD MSc retweeted
Now published in @AmJCardio "Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease"
Full article: authors.elsevier.com/c/1j5bV…
Led by @engelpedro, @DeptVetAffairs, and our team @YaleCardiology
Merilyn Varghese, MD MSc retweeted
Dr. George Goshua has been appointed to the @AnnalsofIM Editorial Board for a 3-year term.
Read more about @GeorgeGoshuaMD and the role.
@YaleHematology @YaleCancer @SmilowCancer
medicine.yale.edu/intmed/new…
Merilyn Varghese, MD MSc retweeted
🚨@AnnalsofIM embargo lift on @YaleMed - @HarvardHPM collaboration:
Quantification of health equity weight thresholds w/ DCEA of gene therapy vs standard-of-care in sickle cell disease @cececalhounMD @SatokoItoMDPhD @LyndonPJames @AndreaLuviano @LakshmananKris7 @AnkurFactorial
1. Original Research =>
acpjournals.org/doi/10.7326/…
2. Call-to-Action Editorial (thank you @RichardACookson) =>
acpjournals.org/doi/10.7326/…
3. The "Why" and Next Steps: medicine.yale.edu/intmed/new…
@NataliaKunst @ADPaltiel @Rsk2003 @LisaSandersmd @LFiellin @hmkyale @DrNunezSmith @redcell_doc @JenniferYuiMD @seethal_jacobmd @Dr_AmerZeidan @AyeshaButtMD @LaylaDoren1 @acweyand @kerstindewit @HanaILim_MD @jlberrymd @justine_ryu @AnnabelFrankMD @DoctorYazanA @amarkelkar @YuxinLiu_03 @PishkoMD @LaurenMerzMD @annap_MD @NTConnell @jd_beckman @heme_fan @Clotmaster @annareisman @MerilynVarghese @Pranay_md @anneliu_md @LaurenPischel @RobertFogerty @NancyLapid @HaemSTAR_UK @VCHResearch @HTRStoday @ASH_hematology
Merilyn Varghese, MD MSc retweeted
📢💫@SatokoItoMDPhD = hematologist+palliative care MD+epidemiologist! Her first @YaleCancer @YaleHematology @YaleMed pub @AnnalsofIM in <6 weeks #GoshuaLab
Editorial doi.org/10.7326/M22-3404
Potent CEA by👏@ShuchiGulati: all oral-Xa inhibitors v LMWH in CAT doi.org/10.7326/M22-1258
Merilyn Varghese, MD MSc retweeted
We can save more lives for our alloimmunized patients medscape.com/viewarticle/985… @medscape
2nd #ASH22 Press Program abstract w/ brilliance from @Yale_LabMed #RGHauser @ChrisTormey3 #JEHendrickson (now Emory), @HarvardHPM @AnkurFactorial and @SatokoItoMDPhD (#GoshuaLab). @YaleCancer
Merilyn Varghese, MD MSc retweeted
Tonight at 7:30pm on Yale Cancer Answers, join us to learn about the field of classical #hematology and current research initiatives into rare blood disorders with @GeorgeGoshuaMD. Listen live on @wnpr or @iTunes. @YaleHemOnc @YaleHematology @SmilowCancer @YaleMed
In our most recent work presented at #AHA22 with simultaneous pub in @CircCQO,
we asked: what was the impact of the COVID-19 pandemic on #cardiacrehab (CR) use among Medicare beneficiaries?
Link: tinyurl.com/8zdjz5sh
Thread: 👇
Where do we go from here?🤔 We need significant innovation in CR financing and delivery, and urgently need to think about the use of novel care models, including virtual CR, to expand access and address widening disparities.
1
4
A special thank you to @kardiologykazi for his invaluable mentorship. Thank you to all our collaborators for their guidance, @AlexisLBeatty
@gcfmd @kevfromRI @rwyeh @joefigs2, and to @SmithBIDMC @BIDMCVfellows @BidmcCvi and @BIDMChealth for their ongoing support!
1
7
Merilyn Varghese, MD MSc retweeted
Marked declines in #CardiacRehab use since the start of the pandemic.
@MerilynVarghese discusses how this may exacerbate disparities in CV outcomes and offers potential solns.
10.15am tomorrow in S104B. Join us!
@SmithBIDMC
The number of Medicare beneficiaries participating in cardiac rehabilitation dropped at the onset of the pandemic and had yet to return to pre-pandemic levels as of December 2021 @kardiologykazi @BIDMChealth @MerilynVarghese #AHA22 #CardioTwitter healio.com/news/cardiology/2…





















